Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00019786
Status:
COMPLETED
Last Update Posted:
2012-03-23
First Post:
2001-07-11
Brief Title:
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Sponsor:
National Institutes of Health Clinical Center CC
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neuroendocrine Carcinoma |
| Colorectal Cancer |
| Islet Cell Tumor |
| Liver Cancer |
| Metastatic Cancer |
Keywords:
| Name | View |
|---|---|
| neuroendocrine carcinoma | View |
| stage IV colon cancer | View |
| stage IV rectal cancer | View |
| recurrent colon cancer | View |
| recurrent rectal cancer | View |
| localized unresectable adult primary liver cancer | View |
| recurrent adult primary liver cancer | View |
| recurrent islet cell carcinoma | View |
| adult primary hepatocellular carcinoma | View |
| adenocarcinoma of the colon | View |
| adenocarcinoma of the rectum | View |
| liver metastases | View |
| adult primary cholangiocellular carcinoma | View |
| advanced adult primary liver cancer | View |
| recurrent childhood liver cancer | View |
| childhood hepatocellular carcinoma | View |
| stage III childhood liver cancer | View |
| stage IV childhood liver cancer | View |